4.2 Article

The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis

Journal

HUMAN IMMUNOLOGY
Volume 76, Issue 1, Pages 22-29

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2014.12.008

Keywords

Th17; Systemic sclerosis; Skin lesion

Categories

Funding

  1. Science and Technology Program of Science and Technology Department of Shaanxi Province, China [2010K16-04]
  2. Research Foundation of the First Affiliated Hospital of Xi'an Jiaotong University [2007YK.5]
  3. National Natural Science Foundation of China [81201373]

Ask authors/readers for more resources

Objective: The objective was to survey the expression and localization of Th17-related cytokines and their correlation with skin lesion severity in early systemic sclerosis (SSc). Methods: The mRNA expression was detected by real-time quantitative polymerase chain reaction (RT-qPCR) from 21 SSc patients and 12 healthy controls (HC). The protein expression was examined by immunohistochemistry (IHC) and Western blotting. Results: The RT-qPCR analysis showed a significantly higher expression of IL-17A, IL-21, IL-22, IL-26, IL-17RA, IL-21R, and IL-22R1 mRNA; consistently, the IHC analysis showed an over-expression of IL-17RA, IL-21R and IL-22R1 and the Western blotting analysis showed an over-expression of IL-17A, IL-21, IL-21R and IL-22R1 in early SSc skin lesions. The mRNA levels of IL-21 were higher in diffuse cutaneous than limited cutaneous SSc lesions. The mRNA expression of IL-26, IL-22, IL-22R1, mRNA and protein expression of IL-17A, IL-21, IL-21R were positively correlated with the modified Rodnan skin score of SSc. In addition, the mRNA levels of ICAM-1 were positively correlated with IL-17A/IL-17RA, and VEGFA and IL-4 were both positively correlated with IL-21/IL-21R, while TGF-beta were moderately negatively correlated with IL-22/IL-22R1. Conclusions: Th17 cytokines contribute to progression in early SSc skin lesions. IL-21/IL-21R could act as potential biomarkers presenting early SSc skin lesions severity. (C) 2014 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available